-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's right to use underlying asset under operating lease.
-
Summary
-
Neuphoria Therapeutics Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q2 2023 to Q3 2025.
- Neuphoria Therapeutics Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $75,219, a 61.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)